Exploring the sleep aid scene, Delivra Health Brands (TSXV: DHB) stands out in Q1-FY2024. With the growing recognition of sleep's role in well-being, the sector is changing.
In Q1, Delivra's strong performance shows a big 112% YoY revenue jump and a higher gross margin at 54%. Most sales, 80%, are now from the U.S. and Middle East, a smart move in this changing sector.
Their flagship Dream Water product taps into the importance of sleep awareness.
Looking ahead, a potential U.S. launch of LivRelief, their pain relief product, expands their reach, indicating more opportunity and growth.
*FRC provides issuer paid coverage.
*Past performance is not indicative of future results.